Growing inorganically can help your company pivot, innovate and growth fast. However, it is a complex process that requires knowledge of market, players, assets development and where a deal must be done fast and at the right time. We can help you be ahead with customized solutions, achieve your business objectives and create long term value through M&A, licensing, investment, and strategic partnering.
Investment / M&A
GoQing will help you with the end–to–end process from scouting, valuation, due diligence to deal closure for your investment and/or acquisition within Life sciences:
- Access to extensive database of small to medium size start–ups / biotechs within Life Sciences in CN, US and EU
- Review selected top 10 to 15 targets and draft rational for interest highlighting synergies / complementarity to portfolio and strategy
- Prioritize and deep dive in top 3 targets (company overview, portfolio, strategy, capabilities,…
- Select with client target with the right fit / synergies and initiate / facilitate the first meetings
- Support client with business approach, valuation, due diligence, deal structure, agreement drafting, negotiation etc.
- Support client with presentation of business case to the executive leadership team
- Support client with final negotiations and deal closure as needed Investment / M&A
In-licensing
GoQing will help you in the various in–licensing steps from scouting to signing the deal:
- Review western biotech targets with the right innovative assets fitting Chinese Pharma portfolio and strategy
- Prioritize targets and deep dive in top 3 assets (pre–due–diligence)
- Support with valuation and confirmatory due–diligence of selected asset and target
- Propose deal structure in order to get the exclusive rights to develop and commercialize in CN or global rights to early stage asset for development and commercialization in US and EU
- Presentation of business case to the executive leadership team
- Support with negotiations and deal closure as needed
Out-licensing
GoQing will help you with the various out–licensing steps from scouting for licensee to signing the deal:
- Review western medium size Pharma interested to in–license assets from Chinese biotechs – draft rational for interest highlighting portfolio and strategy
- Prioritize targets and deep dive in top 3 (company overview, portfolio, strategy, …)
- Support Chinese licensor drafting licensing asset and potential deal structure
- Approach potential licensees and facilitate first meetings / negotiation
- Support Chinese licensor with valuation and confirmatory due–diligence Q&A
- Presentation of business case to the executive leadership team of Chinese licensor
- Support with final negotiations and deal closure as needed
